🇺🇸 FDA
Patent

US 6475724

Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

expired A61PA61P27/06

Quick answer

US patent 6475724 (Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders) held by The Regents of the University of California expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P27/06